APYX icon

Apyx Medical
APYX

18 hedge funds and large institutions have $3.64M invested in Apyx Medical in 2014 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

0.14% less ownership

Funds ownership: 5.45% → 5.3% (-0.14%)

7% less capital inflows, than outflows

Capital inflows: $175K | Capital outflows: $189K

14% less funds holding

Funds holding: 21 → 18 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
+$73.6K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$61.7K
3
BFA
BlackRock Fund Advisors
California
+$17.5K
4
Northern Trust
Northern Trust
Illinois
+$14.7K
5
BA
BlackRock Advisors
Delaware
+$7.65K

Top Sellers

Rank Fund Capital Flow
1
Creative Planning
Creative Planning
Kansas
-$70K
2
VKH
Virtu KCG Holdings
New York
-$62K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$25.3K
4
Renaissance Technologies
Renaissance Technologies
New York
-$25K
5
TDC
Thompson Davis & Co
Virginia
-$4.42K

APYX Hedge Fund Activity: Q1 2014 in Review

18 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q1 2014, worth a combined $3.64M — up 77% from $2.06M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of APYX and 1 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 4 added.

The largest buyer was UBS AM, opening a new position worth an estimated $73.6K. The largest seller was Creative Planning, exiting entirely with an estimated $70K sold.

  • 18 institutional investors held Apyx Medical (APYX) as of Q1 2014, down from 21 in Q4 2013.
  • Funds reported $3.64M of Apyx Medical stock for Q1 2014, up 77% quarter-over-quarter.
  • 1 fund opened new Apyx Medical positions in Q1 2014 and 4 closed out, a net change of -3 holders.
  • The largest Apyx Medical buyer in Q1 2014 was UBS AM, an estimated $73.6K added.
  • The largest Apyx Medical seller in Q1 2014 was Creative Planning, an estimated $70K sold.

Based on aggregated 13F filings for Q1 2014.